Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

Moderna provides updates on its business and pipeline progress at the J.P. Morgan Healthcare Conference.

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

SAGE-689 is under clinical development by Sage Therapeutics and currently in Phase I for Unspecified Central Nervous System Disorders.

FesariusTherapeutics Inc, an emerging bioregenerative technology company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care, Reconstructive Surgery ...

KNEX Technology, a leading Oracle Cloud solutions provider, is proud to announce that its Chief Technology Officer, Gustavo Gonzalez, has been elected as the 2025 President-Elect of the Oracle ...

Sage Therapeutics’ shares jumped over 45% to $8.09 in after-hours on Friday, after the company confirmed that biotech major ...

Collagen is more popular than ever because of its potential anti-aging benefits. There's a lot you need to know before you ...